Bactericidal/permeability-increasing protein inhibits growth of a strain of Acholeplasma laidlawii and L forms of the gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 9, 1999, Pages 2314-2316

  Horwitz, Arnold H ^a   Williams, Robert E ^a   Liu, Pei Syan ^a   Nadell, Rossana ^a  

^a XOMA Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACHOLEPLASMA LAIDLAWII; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; STREPTOCOCCUS PYOGENES;

EID: 0032826017     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.9.2314     Document Type: Article

References (10)

1. Elsbach, P., and J. Weiss. 1992. Oxygen-independent antimicrobial systems of phagocytes, p. 603-636. In J. I. Gallin, I. M. Goldstein, and R. Snyderman (ed.), Inflammation: basic principles and clinical correlates, 2nd ed. Raven Press, New York, N.Y.
2. Elsbach, P., and J. Weiss. 1993. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 187:417-429.
3. Gazzano-Santoro, H., J. B. Parent, L. Grinna, A. Horwitz, T. Parsons, G. Theofan, P. Elsbach, J. Weiss, and P. J. Conlon. 1992. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60:4754-4761.
4. Horwitz, A. H., R. E. Williams, and G. Nowakowski. 1995. Human lipopolysaccharide binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein. Infect. Immun. 63:522-527.
5. Horwitz, A. H., S. D. Leigh, S. Abrahamson, H. Gazzano-Santoro, P.-S. Liu, R. E. Williams, S. F. Carroll, and G. Theofan. 1996. Expression and characterization of cysteine-modified variants of an amino terminal fragment of bactericidal/permeability-increasing protein. Protein Expr. Purif. 8:28-40.
6. In't Veld, G., B. Mannion, J. Weiss, and P. Elsbach. 1988. Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles. Infect. Immun. 56:1203-1208.
7. Kenney, G. 1991. Mycoplasmas, p. 478-482. In A. Balows, W. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
8. Madoff, S. 1986. Introduction to the bacterial L-forms, p. 1-20. In S. Madoff (ed.), The bacterial L-forms. Marcel Dekker, Inc., New York, N.Y.
9. Mannion, B. A., J. Weiss, and P. Elsbach. 1990. Separation of the sub-lethal and lethal effects of the bactericidal/permeability-increasing protein on Escherichia coli. J. Clin. Investig. 85:853-360.
10. Weiss, J., P. Elsbach, C. Shu, J. Castillo, L. Grinna, A. Horwitz, and G. Theofan. 1992. Human bactericidal/permeability-increasing protein and a recombinant N-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit TNF release induced by the bacteria. J. Clin. Investig. 90:1122-1130.